Yingnan Yang

Zhejiang Chinese Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index1.7kcitations103works4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related molecular mechanisms research(12), Anaerobic Digestion and Biogas Production(10), Esophageal Cancer Research and Treatment(10), RNA modifications and cancer(9), Biofuel production and bioconversion(8)

Publications103 total

Novel long noncoding RNA lnc_2217 regulates zygotic genome activation through miR-877-3p/YTHDF2 pathway in goat
Theriogenology·2025
A Heparin‐Functionalized Scaffold with HB‐EGF Immobilization for Tissue Engineering
Advanced Healthcare Materials·2025Open Access
AB004. Optimizing surgical strategies in mediastinal tumor resections through comparative analysis of hemi-clamshell and sternotomy techniques
Mediastinum·2025Open Access
Impact of the intracellular mechanical microenvironment of breast cancer and normal mammary epithelial cells on magnetic hyperthermia of Fe3O4 nanoparticles
Acta Biomaterialia·2025· 1 cited
KDM5B impairs oocyte quality and causes embryo arrest via epigenetic regulation of spindle assembly and chromosome arrangement
Theriogenology·2025· 1 cited
272. CAMRELIZUMAB, PACLITAXEL AND NEDAPLATIN AS CONVERSION THERAPY FOR LOCALLY ADVANCED/ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II, SINGLE-ARM STUDY
Diseases of the Esophagus·2025
287. CAMRELIZUMAB, PACLITAXEL AND NEDAPLATIN AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESPRIT): A PHASE II, SINGLE-ARM STUDY
Diseases of the Esophagus·2025Open Access
Integration of Lean Construction and BIM in Sustainable Built Environment: A Review and Future Research Directions
Buildings·2025· 3 citedOpen Access
Modeling the Enablers for Blockchain Technology Adoption in the Construction Supply Chain
Journal of Construction Engineering and Management·2025
Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research.
Journal of Clinical Oncology·2025
Camrelizumab combined with paclitaxel and nedaplatin as conversion therapy for locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm exploratory study.
Journal of Clinical Oncology·2025
RNA splicing and alternative polyadenylation profile during sheep zygotic genome activation
Biology of Reproduction·2025· 2 citedOpen Access
GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway
Journal of Clinical and Translational Hepatology·2025Open Access
Differential intracellular influence of cancer cells and normal cells on magnetothermal properties and magnetic hyperthermal effects of magnetic nanoparticles
Materials Horizons·2025· 2 citedOpen Access
H3K4me3 Genome-Wide Distribution and Transcriptional Regulation of Transposable Elements by RNA Pol2 Deposition
International Journal of Molecular Sciences·2024· 3 citedOpen Access
Automated construction site layout design system for prefabricated buildings using transformer based conditional GAN
Advanced Engineering Informatics·2024· 8 cited
METTL3-mediated deficiency of lncRNA HAR1A drives non-small cell lung cancer growth and metastasis by promoting ANXA2 stabilization
Cell Death Discovery·2024· 10 citedOpen Access
OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1
Biology Direct·2024· 21 citedOpen Access
Comparative transcriptome analysis provides molecular insights into heterosis of waterlogging tolerance in Chrysanthemum indicum
BMC Plant Biology·2024· 4 citedOpen Access
Exploring the processes and mechanisms by which nonprofit organizations orchestrate global innovation networks: A case study of the COVAX program
Heliyon·2024· 6 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Xiaodong Ling(9), Shigeki Sawayama(7), Luquan Zhang(7), Jianqun Ma(7), Kenichiro Tsukahara(5), Chengyuan Fang(5), Jinhong Zhu(5), Hongming Xie(5), Chika Tada(4), Zhenya Zhang(4), Dayong Zheng(4), Yanzhong Xin(4), Yu Han(3), Heng-heng Yuan(3), Xiaoli Wei(3), Huajie Cai(3), Shouzhang Yang(3), Rui Sun(3), Huajian Chen(3), Toru Yoshitomi(3)